Spain Patient Support Programs (PSP) Market Report 2022 to 2030

Spain Patient Support Programs (PSP) Market Analysis

$ 3999$ 2999

Spain's Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of 8.9% for the year 2022-30. Continuous monitoring and assistance required for the management of chronic diseases and the implementation of smarter technologies in Spain are driving the Spain Patient Support Programs (PSP) market. The market is segmented by functionality outlook, therapeutic outlook, application outlook, and the end user. Some of the major PSP operators in the Spain Patient Support Programs (PSP) market include Ashfield Engage, Evidenze, and Clover

ID: IN10ESHS014 CATEGORY: Healthcare Services GEOGRAPHY: Spain AUTHOR: Parul Choudhary

Buy Now

Spain Patient Support Programs (PSP) Market Executive Analysis

Spain's Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of 8.9% for the year 2022-30. One of the most popular travel destinations in Europe, Spain is also home to some of the world's top universities. The healthcare system in Spain is considered to be one of the best in the world. It provides universal healthcare across Spain and is mostly funded by social security contributions from taxpaying citizens.

The budget allotted to the Ministry of Health in 2023 will rise by 6.5%, totalling $3322.15 Mn, in the context of a decentralized healthcare system where spending by the Spanish Ministry of Health accounts for less than 3% of overall government spending. This amount reflects the distribution of funding from the national public budget for 2023 as well as the European Recovery and Resilience Facility. Notably, $3.43 Mn and $4.50 Mn are allotted to the newly established National Public Health Agency and the national network for public health surveillance, respectively. A further $1409.29 Mn has been set up for the centralized purchase of the COVID-19 vaccine.

Through promoting treatment adherence, enhancing clinical outcomes, enhancing patient experience, and enhancing the quality of life, patient support programs seek to offer answers that go beyond the medicine itself. Spanish patient support programs are created to give patients access to knowledge, instruction, and services that can help them manage their medical conditions. These initiatives seek to enhance patients' quality of life while guiding them through Spain's intricate healthcare system. To assist patients in understanding their diseases and available treatments, many patient support organizations in Spain offer educational materials. Some examples of patient support programs in Spain include AEAL (Spanish Association of Patients with Lymphoma, Myeloma, and Leukemia), FEDER (Spanish Federation of Rare Diseases), and ACCU Spain (Spanish Association of Crohn's and Ulcerative Colitis).

spain patient support program market analysis

Market Dynamics

Market Growth Drivers

In Spain, chronic conditions like diabetes, heart disease, and cancer are becoming more common. PSP can offer the continuing monitoring and assistance that these diseases demand. The need for PSP is anticipated to increase as the population ages. Delivering PSP to patients has become simpler due to technological developments like telemedicine and smartphone applications. This could boost PSP effectiveness and patient involvement, both of which could contribute to the Spain PSP market expansion.

Market Restraints

Significant time, money, and human capital are needed for PSP implementation and administration. The expansion of the Spain PSP market can be limited by the lack of resources for investment in PSP by small and mid-sized pharmaceutical businesses. In order to adopt PSP, patient data privacy is a crucial problem, and businesses must adhere to the General Data Protection Regulation (GDPR). Concerns regarding data privacy may prevent some patients from taking part in PSP.

Major Patient Support Programs in Spain

Patient Support Programs	Focus Area	Pharma Sponsor
KabiCare	Autoimmune diseases	Fresenius Kabi
Abbvie Care	Parkinson, Immunology, Neonatology, and soon starting with Oncology	Abbvie
Connect 360	AstraZeneca therapies	AstraZeneca
Atopic KIDS	Atopic dermatitis	Sanofi
Parkinson's Well-Being Map	Parkinson	UCB
Ayuda Múltiple	Relapsing MS	Teva
Humanitarian Program for Rare Diseases	Rare disease (lysosomal storage disorders)	Sanofi
MultiplicArte 2022	Multiple sclerosis (MS)	Bristol Myers Squibb
Spanish association of people affected with lung cancer	Lung Cancer	Takeda
Sharing Health 2.0	Pompe- Rare Disease	Sanofi
Em One to One	Multiple Sclerosis (MS)	Sanofi
Sanofi with diabetes	Diabetes Mellitus	Sanofi

Top PSP Operators in Spain

Ashfield Engage- Ashfield Engage is a leading provider of field nursing, contact center, and omnichannel patient care services to the healthcare industry that provides state-of-the-art patient engagement programs
Evidenze- Evidenze's PSPs division designs and develops the best solution for patient-oriented programs both in the field of clinical research and in the support environment
Clover- Clover patient solutions is vertical from clover health (Tandem Group- parent company) which works in patient support solutions. It designs and implements patient support solutions to improve health outcomes and greater value for industry and healthcare professionals.
Marti Farm- Marti Farm is a pharma consultancy company, that helps develop products and comply with safety procedures with their intricate workflows
Alcura- Alcura offers comprehensive support in all phases of clinical trials and works with patients, through programs for hospitals and companies, offering them support and help in their treatments

Healthcare Policies and Regulatory Landscape

Patient support programs were mentioned in Royal Decree 957/2020, of 3 November, on the regulation of non-interventional studies of medicinal products for human use. Despite the rise of patient support programs ("PSPs") in recent years, up-to-date regulation on such programs has been relatively scarce.

According to RD 957/2020, it is forbidden to run or sponsor observational studies (OS) with the objective to promote medicines. Then it adds that PSPs under which information is gathered through “planned contacts with patients” can only be carried out in Spain under a protocol that contemplates any of the purposes identified in the definition of observational studies. According to Catalonian guidelines on PSP, the programs must serve to help the patients understand the development of the disease, improve their quality of life or contribute to adequate compliance with the treatment. In Spain, only health care professionals (HCPs) or patient organizations are allowed to communicate PSPs to patients.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Spain Patient Support Programs Market Segmentation

By Functionality Outlook

Communication
Health Tracking & Insights
Billing & Payments
Administrative
Patient Education
Others

By Therapeutic area outlook

Health & Wellness
Chronic Disease Management
Others

By Application outlook

Population Health Management
Outpatient Health Management
In-patient Health Management
Others

By End-user

Payers
Providers
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.